Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
1
|
| pubmed:dateCreated |
1999-2-10
|
| pubmed:abstractText |
The prevalence of myasthenia gravis (MG) among middle-aged and older patients has increased. Patients with early-onset MG live longer than before, but there is also an increase in late-onset MG (onset of the disease after the age of 50 years in patients with no clinical or paraclinical evidence of a thymoma). Epidemiological data support using the age of 50 years to separate early- and late-onset MG. The main immunological difference between early- and late-onset MG is the presence of antibodies to muscle titin, which are detected in approximately 50% of patients with late-onset MG. Treatment of late-onset MG has to be tailored both to the age of the patient and to the immunological findings of that particular form of MG.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
AIM
|
| pubmed:status |
MEDLINE
|
| pubmed:month |
Jan
|
| pubmed:issn |
0003-9942
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
56
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
25-7
|
| pubmed:dateRevised |
2004-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:9923757-Age of Onset,
pubmed-meshheading:9923757-Female,
pubmed-meshheading:9923757-Humans,
pubmed-meshheading:9923757-Male,
pubmed-meshheading:9923757-Middle Aged,
pubmed-meshheading:9923757-Myasthenia Gravis,
pubmed-meshheading:9923757-Norway,
pubmed-meshheading:9923757-Prevalence
|
| pubmed:year |
1999
|
| pubmed:articleTitle |
Late-onset myasthenia gravis: a changing scene.
|
| pubmed:affiliation |
Department of Neurology, University of Bergen, Norway.
|
| pubmed:publicationType |
Journal Article
|